2 days ago by msn.com
The $11.5 billion deal expands the Waltham-based laboratory equipment firm’s ability to detect infectious diseases, including the new coronavirus. read more...
The $11.5 billion deal expands the Waltham-based laboratory equipment firm’s ability to detect infectious diseases, including the new coronavirus.
Thermo Fisher is buying Qiagen in a $11.5 billion deal that expands the laboratory equipment maker’s ability to detect infectious diseases.
Thermo Fisher Scientific has agreed to acquire QIAGEN for approximately $11.5 billion cash, in a deal designed to bolster the buyer’s molecular diagnostics capabilities with QIAGEN’s new coronavirus test and other infectious disease assays.